Credit Suisse Starts Kite Pharma (KITE) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Oil drops more than $2 despite new US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Cowen Starts Kite Pharma (KITE) at Outperform
July 15, 2014 7:45 AM EDTCowen initiated coverage on Kite Pharma (NASDAQ: KITE) with an Outperform rating.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
... MoreStifel Nicolaus Starts Kite Pharma (KITE) at Buy
July 15, 2014 7:44 AM EDTStifel Nicolaus initiated coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $31.00.
For an analyst ratings summary and ratings history on Kite Pharma click here. For more ratings news on Kite Pharma click here.
Shares of Kite Pharma closed at $24.05 yesterday.
... MoreJefferies Starts Kite Pharma (KITE) at Buy
July 15, 2014 6:41 AM EDTJefferies initiates coverage on Kite Pharma (NASDAQ: KITE) with a Buy rating and a price target of $35.00.
Analyst Biren Amin comments, "KITE shares hold significant promise based on PI/II data with KTE-C19 observing robust responses in... More
